Financhill
Back

The Consumer Staples Sel SectSPDR® ETF Vs. Cytokinetics Industry Stock Comparison

Buy
53

XLP
The Consumer Staples Sel SectSPDR® ETF

Last Price:
76.93
Seasonality Move:
0.76%
Buy
55

CYTK
Cytokinetics

Last Price:
53.96
Seasonality Move:
7.55%
Buy
53
The Consumer Staples Sel SectSPDR® ETF (XLP) is a Buy

Is The Consumer Staples Sel SectSPDR® ETF a Buy, Sell or Hold?

  • The current The Consumer Staples Sel SectSPDR® ETF [XLP] share price is $76.95. The Score for XLP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • XLP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XLP Stock Price Chart

What is The Consumer Staples Sel SectSPDR® ETF's stock price today?

  • The The Consumer Staples Sel SectSPDR® ETF share price today is $76.95
    The current trend is moderately bearish and XLP is experiencing buying pressure, which is a positive indicator for future bullish movement.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $53.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

XLP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 49.39 Sell
Chaikin Money Flow: 7246417 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.76 - 77.98) Sell
Bollinger Bands (100): (73.76 - 76.92) Buy

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.04 Sell
Relative Strength Index (14 RSI): 46.58 Sell
Chaikin Money Flow: 781761 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.51 - 58.99) Sell
Bollinger Bands (100): (57.71 - 76.51) Sell

XLP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.39 Sell
20-day SMA: 77.31 Sell
50-day SMA: 76.18 Buy
200-day SMA: 72.75 Buy
8-day EMA: 77.18 Sell
20-day EMA: 77.14 Sell
50-day EMA: 76.46 Buy
200-day EMA: 74.25 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.47 Buy
20-day SMA: 52.83 Buy
50-day SMA: 60.85 Sell
200-day SMA: 55.3 Sell
8-day EMA: 53.07 Buy
20-day EMA: 54.08 Sell
50-day EMA: 58.8 Sell
200-day EMA: 57.11 Sell

The Consumer Staples Sel SectSPDR® ETF Earnings Growth & XLP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.

The Consumer Staples Sel SectSPDR® ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):